Abstract
Predicting the binding mode of flexible polypeptides to proteins is an important task that falls outside the domain of applicability of most small molecule and protein−protein docking tools. Here, we test the small molecule flexible ligand docking program Glide on a set of 19 non-α-helical peptides and systematically improve pose prediction accuracy by enhancing Glide sampling for flexible polypeptides. In addition, scoring of the poses was improved by post-processing with physics-based implicit solvent MM- GBSA calculations. Using the best RMSD among the top 10 scoring poses as a metric, the success rate (RMSD ≤ 2.0 Å for the interface backbone atoms) increased from 21% with default Glide SP settings to 58% with the enhanced peptide sampling and scoring protocol in the case of redocking to the native protein structure. This approaches the accuracy of the recently developed Rosetta FlexPepDock method (63% success for these 19 peptides) while being over 100 times faster. Cross-docking was performed for a subset of cases where an unbound receptor structure was available, and in that case, 40% of peptides were docked successfully. We analyze the results and find that the optimized polypeptide protocol is most accurate for extended peptides of limited size and number of formal charges, defining a domain of applicability for this approach.
Author supplied keywords
- 08
- 12
- 18
- 20
- 2015
- 3 e cândido a
- Acute inflammation
- Adhesion molecules
- Anakinra (PubChem CID: 90470007)
- BAY-11-7082 (PubChem CID: 5353431)
- Behavioral disorders
- Cancer
- Chronic inflammation
- Colitis
- Colonic fermentation
- Colorectal cancer
- Cyclomodulin
- DHA
- Dectin-1
- Diabetes
- Dietary fiber
- Dysbiosis
- EPA
- Environmental factors
- Fructo-oligosaccharides
- Galacto-oligosaccharides
- Glyburide (PubChem CID: 3488)
- Growth and development
- Gut microbiota
- Gut-Lung Axis
- Hydroxybutyrate (PubChem CID: 441)
- ISAPP
- Inflammasome
- Inflammasomes
- Inflammation
- Inhibitors
- Innate immunity
- MCC950 (PubChem CID: 9910393)
- Machine learning
- Medicinal plant
- Medicinal plants
- Microbiome
- Microbiota
- Mycobiota
- N-acetyl Cysteine (PubChem CID: 12035)
- NLRP
- Oligosaccharide
- Omega-3 PUFAs
- Organelle
- Oxidative stress
- Prebiotic
- Prebiotics
- Probiotic
- Proteomics
- Respiratory disease
- Ritonavir (PubChem CID: 392622)
- Secondary metabolites
- Short chain fatty acids
- Short-chain fatty acids
- THP-1 macrophage
- TLRs
- Thalidomide (PubChem CID: 5426)
- Therapeutics
- Therapy
- Treatment outcome
- VX-740 (PubChem CID: 153270)
- VX-765 (PubChem CID: 11398092)
- Zea mays
- altura da inserção da espiga
- altura da planta
- anna christina de almeida
- antibiotic
- aprovado para publicação em
- autor para correspondência
- bacteria
- beneficial microbes
- colorectal cancer
- consumer preferences
- convencional
- da costa 4
- de cultivo orgânico e
- diet
- digestion
- digestive well-being
- dysbiosis
- fatty acid
- fecal microbiota transplantation
- fermented food
- fermented milk
- food ingestion
- functional food
- grãos
- gut fermentation
- health benefits
- health-promoting gut bacteria
- icle
- kefir
- kimchi
- kombucha
- lucinéia de pinho 1
- maria cristina d
- melhoramento genético
- microbiome
- microbiota
- microorganisms
- miso
- natto
- nutraceuticals
- nutritional supplement
- omega-3
- organic production
- paes 2
- pharmabiotic
- prebiotic
- prebiotics
- probiosis
- probiotic
- prolificidade
- recebido para publicação em
- satiety
- sauerkraut
- sourdough
- soy
- spikelets
- study
- taste
- tempeh
- β-glucan
- Киари
Cite
CITATION STYLE
Garrett, W. S., Lordan, C., Thapa, D., Ross, R. P., Cotter, P. D., 马树庆, … Antitumoral, T. (2020). 済無No Title No Title. Gut. Retrieved from https://doi.org/10.1016/j.ijbiomac.2019.08.035%0Ahttps://doi.org/10.1053/j.gastro.2020.05.059%0Ahttps://doi.org/10.1016/j.plaphy.2020.01.006%0Ahttp://dx.doi.org/10.1016/j.chom.2014.02.007%0Ahttps://doi.org/10.1007/s13197-020-04244-5%0Ahttp://dx.doi.org/10
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.